217 related articles for article (PubMed ID: 33135714)
1. Nanobody-displaying porous silicon nanoparticles for the co-delivery of siRNA and doxorubicin.
Tieu T; Wojnilowicz M; Huda P; Thurecht KJ; Thissen H; Voelcker NH; Cifuentes-Rius A
Biomater Sci; 2021 Jan; 9(1):133-147. PubMed ID: 33135714
[TBL] [Abstract][Full Text] [Related]
2. Delivery of siRNA in vitro and in vivo using PEI-capped porous silicon nanoparticles to silence MRP1 and inhibit proliferation in glioblastoma.
Tong WY; Alnakhli M; Bhardwaj R; Apostolou S; Sinha S; Fraser C; Kuchel T; Kuss B; Voelcker NH
J Nanobiotechnology; 2018 Apr; 16(1):38. PubMed ID: 29653579
[TBL] [Abstract][Full Text] [Related]
3. Co-loading of photothermal agents and anticancer drugs into porous silicon nanoparticles with enhanced chemo-photothermal therapeutic efficacy to kill multidrug-resistant cancer cells.
Xia B; Zhang Q; Shi J; Li J; Chen Z; Wang B
Colloids Surf B Biointerfaces; 2018 Apr; 164():291-298. PubMed ID: 29413608
[TBL] [Abstract][Full Text] [Related]
4. Cancer-targeting siRNA delivery from porous silicon nanoparticles.
Wan Y; Apostolou S; Dronov R; Kuss B; Voelcker NH
Nanomedicine (Lond); 2014 Oct; 9(15):2309-21. PubMed ID: 24593001
[TBL] [Abstract][Full Text] [Related]
5. Systematic Evaluation of Transferrin-Modified Porous Silicon Nanoparticles for Targeted Delivery of Doxorubicin to Glioblastoma.
Luo M; Lewik G; Ratcliffe JC; Choi CHJ; Mäkilä E; Tong WY; Voelcker NH
ACS Appl Mater Interfaces; 2019 Sep; 11(37):33637-33649. PubMed ID: 31433156
[TBL] [Abstract][Full Text] [Related]
6. A self-assembled polyjuglanin nanoparticle loaded with doxorubicin and anti-Kras siRNA for attenuating multidrug resistance in human lung cancer.
Wen ZM; Jie J; Zhang Y; Liu H; Peng LP
Biochem Biophys Res Commun; 2017 Dec; 493(4):1430-1437. PubMed ID: 28958938
[TBL] [Abstract][Full Text] [Related]
7. Near-infrared light and magnetic field dual-responsive porous silicon-based nanocarriers to overcome multidrug resistance in breast cancer cells with enhanced efficiency.
Li J; Zhang W; Gao Y; Tong H; Chen Z; Shi J; Santos HA; Xia B
J Mater Chem B; 2020 Jan; 8(3):546-557. PubMed ID: 31854435
[TBL] [Abstract][Full Text] [Related]
8. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery.
Ma X; Zhao Y; Ng KW; Zhao Y
Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533
[TBL] [Abstract][Full Text] [Related]
9. Small interfering RNA delivery by polyethylenimine-functionalised porous silicon nanoparticles.
Hasanzadeh Kafshgari M; Alnakhli M; Delalat B; Apostolou S; Harding FJ; Mäkilä E; Salonen JJ; Kuss BJ; Voelcker NH
Biomater Sci; 2015 Dec; 3(12):1555-65. PubMed ID: 26343506
[TBL] [Abstract][Full Text] [Related]
10. Porous Silicon Nanocarriers with Stimulus-Cleavable Linkers for Effective Cancer Therapy.
Xue Y; Bai H; Peng B; Tieu T; Jiang J; Hao S; Li P; Richardson M; Baell J; Thissen H; Cifuentes A; Li L; Voelcker NH
Adv Healthc Mater; 2022 Jun; 11(12):e2200076. PubMed ID: 35306736
[TBL] [Abstract][Full Text] [Related]
11. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy.
Yong T; Zhang X; Bie N; Zhang H; Zhang X; Li F; Hakeem A; Hu J; Gan L; Santos HA; Yang X
Nat Commun; 2019 Aug; 10(1):3838. PubMed ID: 31444335
[TBL] [Abstract][Full Text] [Related]
12. Redox-responsive mesoporous silica nanoparticles: a physiologically sensitive codelivery vehicle for siRNA and doxorubicin.
Ma X; Teh C; Zhang Q; Borah P; Choong C; Korzh V; Zhao Y
Antioxid Redox Signal; 2014 Aug; 21(5):707-22. PubMed ID: 23931896
[TBL] [Abstract][Full Text] [Related]
13. Polyelectrolyte complex templated synthesis of monodisperse, sub-100 nm porous silica nanoparticles for cancer targeted and stimuli-responsive drug delivery.
Newham G; Mathew RK; Wurdak H; Evans SD; Ong ZY
J Colloid Interface Sci; 2021 Feb; 584():669-683. PubMed ID: 33223243
[TBL] [Abstract][Full Text] [Related]
14. EGF-modified mPEG-PLGA-PLL nanoparticle for delivering doxorubicin combined with Bcl-2 siRNA as a potential treatment strategy for lung cancer.
Zhang X; Wang Q; Qin L; Fu H; Fang Y; Han B; Duan Y
Drug Deliv; 2016 Oct; 23(8):2936-2945. PubMed ID: 26739487
[TBL] [Abstract][Full Text] [Related]
15. Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA.
Taratula O; Garbuzenko OB; Chen AM; Minko T
J Drug Target; 2011 Dec; 19(10):900-14. PubMed ID: 21981718
[TBL] [Abstract][Full Text] [Related]
16. Overcoming doxorubicin resistance in cancer: siRNA-loaded nanoarchitectures for cancer gene therapy.
Paskeh MDA; Saebfar H; Mahabady MK; Orouei S; Hushmandi K; Entezari M; Hashemi M; Aref AR; Hamblin MR; Ang HL; Kumar AP; Zarrabi A; Samarghandian S
Life Sci; 2022 Jun; 298():120463. PubMed ID: 35259354
[TBL] [Abstract][Full Text] [Related]
17. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
[TBL] [Abstract][Full Text] [Related]
18. Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer.
Xu C; Wang P; Zhang J; Tian H; Park K; Chen X
Small; 2015 Sep; 11(34):4321-33. PubMed ID: 26136261
[TBL] [Abstract][Full Text] [Related]
19. Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.
Xia Y; Xu T; Wang C; Li Y; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():143-159. PubMed ID: 29317822
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of IL17RB siRNA and doxorubicin by chitosan-based nanoparticles for enhanced anticancer efficacy in breast cancer cells.
Alinejad V; Hossein Somi M; Baradaran B; Akbarzadeh P; Atyabi F; Kazerooni H; Samadi Kafil H; Aghebati Maleki L; Siah Mansouri H; Yousefi M
Biomed Pharmacother; 2016 Oct; 83():229-240. PubMed ID: 27372407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
